Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment

Neal J. Weinreb*, Jack Goldblatt, Jacobo Villalobos, Joel Charrow, J. Alexander Cole, Marcelo Kerstenetzky, Stephan Vom Dahl, Carla Hollak

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

108 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science